JSPRW
Price:
$0.23
Market Cap:
$332.77M
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bon...[Read more]
Industry
Biotechnology
IPO Date
Stock Exchange
NASDAQ
Ticker
JSPRW
According to Jasper Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Jasper Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), JSPRW's Dividend Yield was at its highest in in the December 2019 quarter at 0%. The Dividend Yield was at its lowest in in the December 2019 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Jasper Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
The current Dividend Yield of Jasper Therapeutics, Inc. (JSPRW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Jasper Therapeutics, Inc.’s Dividend Yield is less than Roivant Sciences Ltd. (0%), less than SAB Biotherapeutics, Inc. (0%), less than NRx Pharmaceuticals, Inc. (0%), less than Celularity Inc. (0%), less than eFFECTOR Therapeutics, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $8.80B | |
0% | $32.23M | |
0% | $14.89M | |
0% | $31.66M | |
0% | $2.82K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jasper Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jasper Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Jasper Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Jasper Therapeutics, Inc. (JSPRW)?
What is the highest Dividend Yield for Jasper Therapeutics, Inc. (JSPRW)?
What is the 3-year average Dividend Yield for Jasper Therapeutics, Inc. (JSPRW)?
What is the 5-year average Dividend Yield for Jasper Therapeutics, Inc. (JSPRW)?
How does the current Dividend Yield for Jasper Therapeutics, Inc. (JSPRW) compare to its historical average?